ASML's Demand Outruns Its Capacity While Wall Street Argues Over the Bill
Published on 10/26/2026 at 07:32 | Editorial boerse-global.de
ASML has spent the past fortnight telling two very different stories to two very different audiences. To its customers, the Dutch chip-equipment maker has signalled that demand will outstrip what it can physically supply through 2027 and 2028. To shareholders, it has delivered a blowout quarter, raised its full-year outlook — and absorbed a sell-side downgrade to sell.
Those threads are not as contradictory as they first appear. One describes the business. The other prices the stock.
A quarter that speaks for itself
The company published its third-quarter 2026 figures on 14 October. Revenue came in at €11.662bn, with a net profit of €4.960bn and a gross margin of 57.5%. Those are closed-book numbers, not projections — a distinction that matters when the surrounding noise is all about what comes next.
What comes next is a steep sequential step-up. For the fourth quarter, ASML guides revenue to a range of €14.2bn to €15.2bn. The entire band sits above what the September quarter delivered, meaning the company is effectively calling for a double-digit percentage jump in the closing three months of the year.
Should investors sell immediately? Or is it worth buying ASML Holding?
Zoom out and the full-year picture is equally ambitious: management lifted its 2026 revenue target to €44bn–€45bn, with a gross margin of around 56%. The top line has been raised; the margin figure remains, explicitly, an expectation rather than a result.
The constraint nobody can engineer around
Roughly two weeks ago, ASML acknowledged — according to media reports — that its planned output will not fully cover customer demand. That admission applies to 2027 and 2028, so its relevance stretches well beyond the current fiscal year. No quantified revenue guidance for those years accompanied the statement.
The takeaway for investors is a familiar one in capital-goods cycles: a full order book and a full revenue line are not the same thing. Strong demand sets the ceiling; manufacturing capacity, lead times and supply chains determine what actually gets recognised. ASML has told the market where the ceiling is. Getting there is an operational question, not a demand question.
Buybacks, and a rating that cuts the other way
Alongside the operating update, ASML disclosed share repurchases totalling €352,032,719 for the 12–16 October window. These are executed transactions, not the mere announcement of a programme — capital returned to holders, accounted for separately from revenue and earnings.
Then there is the counterweight. A sell recommendation landed on the stock, and no rationale for that call has been made public. That absence is itself instructive: without the underlying valuation assumptions, the rating is a data point rather than an argument.
When AI scepticism meets a guidance raise
Thursday's trading told a different story from the fundamentals. ASML slid as a broad selloff hit AI-linked equities, with doubts about the returns on AI infrastructure spending — sharpened by Meta's results — at the centre of the move. Worries over oil prices and inflation added to the pressure, and the semiconductor index notched its steepest one-day percentage decline since June. The strain ran well past ASML: investors were re-underwriting the economics of AI capex across the board.
Sentiment and business performance, though, are separate ledgers. Questions about the profitability of AI infrastructure do not rewrite ASML's guidance — but they do change the multiple investors are willing to pay for the revenue growth that guidance implies. That is why the selloff cannot be explained by the latest results alone.
ASML Holding at a turning point? This analysis reveals what investors need to know now.
By Friday, the shares had recovered 0.6%. The bounce softens the mood but does not resolve the tension between a more cautious market and the outlook management has put on paper. For fundamental anchoring, the published results and the guidance remain the firmer reference points.
What investors are actually left to weigh
Strip it back and the picture is genuinely mixed. ASML has posted strong results and raised its annual revenue target. It has bought back €352m of its own stock in a single week. It has also warned that supply will fall short of demand into 2028, drawn a sell rating from at least one analyst, and traded through an industry-wide AI de-rating.
None of those items answers the central question on its own — what the shares are worth. Buybacks say something about capital allocation, a single analyst's rating says something about one set of valuation assumptions, and a sector selloff says something about risk appetite. The operating numbers say something about the business. Keeping those four conversations apart is the only way to read ASML right now.
Ad
ASML Holding Stock: New Analysis - 26 October
Fresh ASML Holding information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
